In human pancreatic myofibroblasts, interleukin (IL)-17 markedly enhances tumor necrosis factor (TNF)-a-induced IL-6 secretion through the induction of IL-6 mRNA stabilization. Induced stability of IL-6 mRNA was markedly decreased by the inhibitors of extracellular signal-regulated kinase (ERKs), PD98059 and U0216. This indicates that activation of the ERK pathway is involved in the induction of IL-6 mRNA stabilization by IL-17 plus TNF-a. D
Introduction
Interleukin (IL)-6 has a range of biological activities including B-and T-cell activation, stimulation of febrile episodes, and release of acute phase response protein [1, 2] . In patients with acute pancreatitis, IL-6 release occurs during the initial stage of disease [3, 4] . We have recently found that human pancreatic myofibroblasts secrete a large amount of IL-6 in response to IL-1h, IL-17, and tumor necrosis factor (TNF)-a [5] . Furthermore, IL-17 markedly enhances TNF-a-induced IL-6 production, mainly through the induction of mRNA stabilization [5] .
Three subgroups of the mitogen-activated protein (MAP) kinase family have been identified [6 -9] . The p44 and p42 extracellular signal-regulated kinase ERK1 and ERK2 responded mainly to mitogenic stimuli, while the Jun NH 2 -terminal kinases (JNK) and p38 responded to cellular stress [6] [7] [8] [9] . Several reports have demonstrated a major role for p38 MAP kinase in regulation of mRNA stabilization [10 -16] . The activation of p38 MAP kinase by forced expression of MAPK kinase (MKK)-6 (an activator of p38) or MAPK-activated protein kinase (MAPKAPK)-2 (a downstream effector of p38) stabilizes the cyclooxigenase-2 mRNA [10, 11] . A similar response has been observed in the IL-6 and IL-8 genes [12] . A role for p38 in inducing mRNA stabilization has also been demonstrated by the use of a specific inhibitor of p38 MAP kinase, SB203580 [13 -16] .
In this study, we investigated the role of ERK1/2 MAPkinase in the induction of IL-6 mRNA stabilization by IL-17 and TNF-a. By using a specific inhibitor of mitogenactivated protein kinase kinase (MEK) 1 and 2, which are the kinases directly upstream to ERK1/2 [17, 18] , we demonstrated that ERK1/2 play an important role in the induction of IL-6 mRNA stabilization by IL-17 plus TNF-a.
Materials and methods

Reagents and cells
Recombinant human IL-1h, IL-17, and TNF-a were obtained from R&D Systems (Minneapolis, MN). The inhibitor of MEK (PD98059 and U0216) and the inhibitor of p38 MAPK (SB203580) were purchased from Cell Signaling Technology (Beverly, MA) [17 -19] . All other reagents used in this study were purchased from Sigma Chemical Co. (St. Louis, MO). Normal human pancreatic tissue was obtained and maintained as described in our previous report [5] .
Northern blot analysis
Northern blot was performed according to the method described previously [5] . Stability studies were performed as follows. Pancreatic myofibroblasts were stimulated with or without cytokines for 3 h, washed, and further incubated with MAP kinase inhibitors (20 AM) and actinomycin D (5 Ag/ml) for various time periods. Total RNA was sequentially extracted, and IL-6 mRNA abundance was determined by Northern blotting. IL-6 mRNa abundance was expressed as relative to the corresponding level before addition of actinomycin D (percent remaining). Cytokines were used at the concentrations of IL-17 (200 ng/ml), TNF-a (10 ng/ml), and IL-1h (0.1 ng/ml). The radioactivity of each band of Northern blotting was determined by the Instant Imagerk Electronic Autoradiography system model #2024/417257 (Packard, Meriden, CT). For comparison of radioactivity, each radioactivity was converted to relative radioactivity to the value of medium alone.
Western blot analysis
The cells were exposed to cytokines for 15 min, washed with PBS, and lysed in SDS sample buffer containing 100 AM orthovanadate. Lysates were homogenized and protein content was determined by using the Bradford method. Ten micrograms of protein from each sample was subjected to SDS-PAGE on a 4 -20% gradient gel under reducing conditions. Proteins were then electrophoretically transferred onto a nitrocellulose membrane. The antibodies against phosphorylated and total MAP kinases were purchased from Cell Signaling Technology, and peroxidase-conjugated second antibodies were purchased from Amersham (Arlington Heights, IL). Subsequently, detection was performed using the enhanced chemiluminescence Western blotting system (Amersham).
IL-6 promoter luciferase reporter constructs and cell transfection
Human IL-6 promoter region was amplified by PCR using human genomic DNA [20] as a template with the primers: IL-6 (À 648), ACAGGTAACTACCTGGAGACGCGTTGAA; IL-6 ( + 66), GCTAAGCTTCTGGAGGGGAGATA-GAGCTTC. The 5Vsequence of IL-6 (À 648) was modified for KpnI site, and the 5Vregion of IL-6 ( + 66) was modified for HindIII site, respectively. These fragments were ligated into KpnI and HindIII sites of the luciferase reporter plasmid pGL3-Basic (Promega, Madison, WI) yielding the reporter construct. The sequence of inserts was determined by the auto-sequencer. Transient transfection was performed by using Lipofectamine Plus reagent (GIBCO BRL) according to the manufacturer's instruction. Twenty hours prior to transfection, 1 Â 10 6 cells were plated in triplicate in 35mm wells of a six-well plate. For each well, 1-Ag plasmid DNA and 0.2-Ag h-galactosidase reporter vector pCMVh (CLONTECH, Palo Alto, CA) were cotransfected and incubated for 24 h. Then, the medium was changed and cells were incubated in the presence of stimuli further for 12 h. The luciferase activity was measured by the Luciferase Assay System Kit (Promega) and expressed as relative activity normalized to h-galactosidase activity.
Results
In human pancreatic myofibroblasts, IL-17 markedly enhanced TNF-a-induced IL-6 mRNA expression ( Fig.  1A ) [5] . To investigate the molecular mechanism involved in this response, we initially studied how IL-17 modulates IL-6 promoter activities. As shown in Fig. 1B , IL-17 did not affect TNF-a-induced IL-6 promoter activity, whereas IL-17 increased IL-1h-induced IL-6 promoter activity. These results are compatible with our previous observation that IL-17 did not affect TNF-a-induced NF-nB activation, which plays a critical role in the induction of the IL-6 gene. Taken together, these observations indicate that transcriptional mechanism does not play a major role in the strong enhancement of IL-6 gene expression by the combination of IL-17 plus TNF-a.
As shown in Fig. 2, IL-17 , TNF-a, or IL-17 plus TNF-a induced ERK or p38 MAP kinase phosphorylation. The combination of IL-17 plus TNF-a enhanced ERK and p38 phosphorylation as compared to the effect of either TNF-a of IL-17 alone.
To investigate the role of MAP kinases in the induction of IL-6 mRNA stabilization by IL-17 or TNF-a, we used MAP kinase inhibitors. SB203580 is an inhibitor of p38 MAP kinase [19] . PD98059 and U0216 are inhibitors of MEK, which is an upstream activator of ERK MAP kinase [17, 18] . PD98059 is specific for MEK1, and U0216 is specific for MEK1 and MEK2 [17, 18] . Inhibition of ERK activity by U0216 is stronger than that induced by PD98059. As shown in Fig. 3 , IL-6 mRNA induced by TNF-a or IL-17 was rapidly decreased within 3 h, and the addition of MAP inhibitors dramatically enhanced the rate of IL-6 mRNA decay. These observations indicate that the posttranscriptional regulation mediated by MAP kinase activation is important in the induction of IL-6 mRNA by either TNF-a or IL-17 alone.
As shown in Fig. 4 , the IL-6 mRNA induced by IL-17 plus TNF-a was stable within 5 h. The addition of SB203580 completely blocked IL-17-induced IL-6 mRNA stability. This response was compatible with the previous reports demonstrating the role of the p38 MAP kinase pathway in the induction of mRNA stability [10 -16] .
Similarly, the addition of PD98059 partially inhibited IL-17 plus TNF-a-induced IL-6 mRNA stabilization and U0216 exerted complete inhibition, indicating that the ERK1/2 MAP kinase pathway is involved in the induction of IL-6 mRNA stabilization by IL-17 plus TNF-a.
Discussion
IL-17 is a newly identified T cell-specific cytokine [21 -26] . There is increasing evidence that IL-17 is a mediator of inflammatory responses in various tissues through activation of the NF-nB and MAP kinase pathways [5] . IL-6 induction by IL-17 in pancreatic periacinar myofibroblasts suggests a role for T cells in the pathogenesis of acute pancreatitis [5] .
The most important finding of the present study is that inhibition of ERK 1/2 kinase activity markedly reduced the stability of the IL-6 mRNA induced by IL-17 plus TNF-a. U0216 is an inhibitor of MEK1 and MEK2, and PD98059 is an inhibitor of MEK1 [17, 18] . As demonstrated previously [5] , U0216 exerted a stronger inhibitory effects than PD98059 in the cells used in this study. Consistent with the activities of MAP kinase inhibition, U0216 blocked IL-17 plus TNF-a-induced IL-6 mRNA stabilization more strongly than PD98059, indicating that inhibition of ERK1/2 activity was actually correlated with the destabilization of IL-6 mRNA. In addition, the induction of mRNA stability might be the major mechanism accounting for the IL-17 plus TNF-a-induced increase in IL-6 secretion, since IL-17 did not affect TNF-a-induced IL-6 promoter activity.
The p38 MAP kinase has been reported to play a major role in the induction of mRNA stabilization through AUrich elements in the 3V -untranslated regions [10 -12] . Recent studies demonstrate that ERK MAP kinase is also involved in the induction of mRNA stabilization [27 -29] . AUUUA sequences repeated in the 3V -untranslated region of many cytokine genes were target for rapid degradation and inhibited the translation of the corresponding mRNAs [10 -12] . Six copies of the AUUUA sequences are located in the 3V-untranslated region of IL-6 mRNA [13] . The p38 Fig. 4 . Effects of MAP kinase inhibitors on the stability of TNF-a plus IL-17 induced IL-6 mRNA. IL-6 mRNA stability was assessed by the method described in Materials and methods. Cytokines were used at the concentrations of IL-17 (200 ng/ml) and TNF-a (10 ng/ml), and MAP kinase inhibitors were used at 20 AM.
MAP kinase or its downstream kinases are considered to affect the proteins that bind to the AUUUA sequence of IL-6 mRNA and induce stabilization. Actually, several molecules, such as AUBF, have been identified which bind AU-rich sequences to increase mRNA stability [30] . Accordingly, a protein that destabilizes mRNA was generated rapidly after stimulation, and this action was blocked by the activated p38 MAP kinase [13] . A similar mechanism might be involved in ERK-mediated IL-6 mRNA stabilization, since Sirenco et al. [30] previously reported that formation of the AUUUA sequence-binding complexes and accelerated mRNA turnover involve protein phosphorylation processes. Although they did not provide direct evidence that ERK1/2 MAP kinase participates in the induction of IL-1h and GRO mRNA stabilization, it was suggested that the activation of tyrosine kinase, as well as p38 MAP kinase, might be involved.
In conclusion, the present study indicates that ERK MAP kinase is involved in the induction of IL-6 mRNA stability by IL-17 plus TNF-a. The mechanism mediating mRNA stabilization suggests a central role for p38 MAP kinase, but the mechanisms by which ERK MAP kinase induces the stabilization of IL-6 mRNA require further investigation.
